4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid CAS:106261-48-7

Chemical Name: 4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid
CAS.NO:  106261-48-7
Synonyms:
4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid
Benzoic acid, 4-[(4-methyl-1-piperazinyl)methyl]-
4-[(4-methylpiperazin-1-yl)methyl]benzoic acid
4-(4-Methylpiperazin-1-ylmethyl)benzoic acid

Molecular Formula: C13H18N2O2
Molecular Weight:234.294

Physical and Chemical Properties:
Density: 1.175 g/cm3
Boiling point: 377.198ºC at 760 mmHg
Melting point:/
Flash point:181.923ºC
Refractive index: 1.58

Specification:
Appearance:white crystalline powder
Purity:≥99%

Packing:
 25kg  cardboard drum or according to customer specified requirements
Storage:Stored in a cool and dry well-closed container. Keep away from moisture and strong light/heat.
Application:Intermediates of Imatinib mesylate  CAS: 220127-57-1
Intermediates of Imatinib  CAS:152459-95-5

We are professional 4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid manufacturer and 4-(4-Methylpiperazin-1-ylmethyl)benzoic acid supplier in China, We offer quality 4-(4-Methylpiperazin-1-ylmethyl)benzoic acid you can fully trust, also we have India factory and producer of 4-[(4-methylpiperazin-1-yl)methyl]benzoic acid,Pls send inquiry of 4-[(4-Methyl-1-piperazinyl)methyl]benzoic acid CAS:106261-48-7 to info@nbinno.com if you have any interests, thank you!


Related News: GlaxoSmithKline (GSK) is at the bottom of the top 20 list with the lowest percentage R&D spend/annual revenue at 12%.”4-(TRIFLUOROMETHOXY)BENZOYL CHLORIDE Bulk drug substances mainly include vitamins, antibiotics, hormones, antipyretics and analgesics, among which vitamin C, erythromycin thiocyanate, penicillin, azithromycin, and semi-synthetic cephalosporins are the most concentrated products in the industry in terms of production and overcapacity.2-Methylpyrazine CAS:109-08-0 The company’s pharmaceutical intermediate business is expected to maintain a growth rate of more than 30%.Bis[3-(Triethoxysilyl)Propyl]Tetrasulfide CAS:40372-72-3 Factors that have a significant impact on the sales volume of APIs come from the production side, which mainly includes costs and processes.The CRL for the Cabenuva injection, containing two active ingredients cabotegravir and Janssen’s rilpivirine, follows U.S. market approval in April for its once-a-day pill Dovato, also a two-drug combination.